Author Question: A patient's platelet count drops 4 days after being placed on heparin. Select the correct ... (Read 110 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
A patient's platelet count drops 4 days after being placed on heparin. Select the correct interpretation.
 
  a. The patient has heparin-induced thrombocytopenia.
  b. The patient has benign, limited thrombocytopenia related to heparin.
  c. A bleeding time should be performed to evaluate qualitative platelet disorders.
  d. An immunoassay for heparin-dependent anti-platelet factor 4 (PF4) should be performed to distinguish heparin-induced thrombocytopenia from benign, limited thrombocytopenia related to heparin.

Question 2

A platelet aggregation study shows diminished response to all agonists except for a small response to arachidonic acid and full response to ristocetin. Which condition is most likely?
 
  a. Glanzmann thrombasthenia
  b. Aspirin use
  c. VWD
  d. Platelet release defect



Anton

  • Sr. Member
  • ****
  • Posts: 302
Answer to Question 1

ANS: D
This pattern, a drop in the platelet count 4 days after being placed on heparin, suggests heparin-induced thrombocytopenia. It could also be a benign, limited thrombocytopenia related to heparin. Assays such as the immunoassay for heparin-dependent anti-PF4 can distinguish the two.

Answer to Question 2

ANS: A
Glanzmann thrombasthenia is diagnosed by its diminished secretion and aggregation responses to all agonists except a modest response to arachidonic acid and full, although nondiagnostic, response to ristocetin.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

For a complete list of videos, visit our video library